Dachaigh › Leukemia biphenotypic geur
Sgrùdaidhean clionaigeach Leukemia biphenotypic geur a’ fastadh anns na SA
Tha 37 sgrùdaidhean airson Leukemia biphenotypic geur a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Seattle, WA15 sgrùdaidhean
- Houston, TX11 sgrùdadh
- New York City, NY10 sgrùdaidhean
- Atlanta, GA9 sgrùdaidhean
- Durham, NC8 sgrùdaidhean
- Memphis, TN7 sgrùdaidhean
- Chicago, IL7 sgrùdaidhean
- Charlotte, NC6 sgrùdaidhean
- Aurora, CO6 sgrùdaidhean
- Baldwin Park, CA6 sgrùdaidhean
- Portland, OR6 sgrùdaidhean
- Los Angeles, CA6 sgrùdaidhean
- Philadelphia, PA6 sgrùdaidhean
- Dallas, TX6 sgrùdaidhean
- San Diego, CA5 sgrùdaidhean
- Boston, MA5 sgrùdaidhean
- San Francisco, CA5 sgrùdaidhean
- Tampa, FL5 sgrùdaidhean
- Clifton, NJ5 sgrùdaidhean
- Nashville, TN5 sgrùdaidhean
- Columbus, OH5 sgrùdaidhean
- Greenburgh, NY5 sgrùdaidhean
- Cincinnati, OH5 sgrùdaidhean
- Fort Worth, TX5 sgrùdaidhean
- Minneapolis, MN5 sgrùdaidhean
- Mountain View, CA4 sgrùdaidhean
- Denver, CO4 sgrùdaidhean
- Jacksonville, FL4 sgrùdaidhean
- Milwaukee, WI4 sgrùdaidhean
- Greenville, NC4 sgrùdaidhean
- St. Louis, MO4 sgrùdaidhean
- Kansas City, MO4 sgrùdaidhean
- Omaha, NE4 sgrùdaidhean
- Orange, CA4 sgrùdaidhean
- Akron, OH4 sgrùdaidhean
- Indianapolis, IN4 sgrùdaidhean
- Queens, NY4 sgrùdaidhean
- Washington, DC4 sgrùdaidhean
- Ann Arbor, MI4 sgrùdaidhean
- Baltimore, MD4 sgrùdaidhean
Le stàit
- Alabama3 sgrùdaidhean
- Alaska3 sgrùdaidhean
- Arizona3 sgrùdaidhean
- Arkansas3 sgrùdaidhean
- California15 sgrùdaidhean
- Colorado8 sgrùdaidhean
- Connecticut3 sgrùdaidhean
- Delaware3 sgrùdaidhean
- Florida9 sgrùdaidhean
- Georgia9 sgrùdaidhean
- Hawaii3 sgrùdaidhean
- Idaho3 sgrùdaidhean
- Illinois7 sgrùdaidhean
- Indiana4 sgrùdaidhean
- Iowa4 sgrùdaidhean
- Kentucky4 sgrùdaidhean
- Louisiana4 sgrùdaidhean
- Maine3 sgrùdaidhean
- Maryland4 sgrùdaidhean
- Massachusetts5 sgrùdaidhean
- Michigan4 sgrùdaidhean
- Minnesota6 sgrùdaidhean
- Mississippi3 sgrùdaidhean
- Missouri5 sgrùdaidhean
- Nebraska4 sgrùdaidhean
- Nevada3 sgrùdaidhean
- New Hampshire3 sgrùdaidhean
- New Jersey6 sgrùdaidhean
- New York11 sgrùdadh
- North Carolina11 sgrùdadh
- North Dakota3 sgrùdaidhean
- Ohio8 sgrùdaidhean
- Oklahoma5 sgrùdaidhean
- Oregon6 sgrùdaidhean
- Pennsylvania6 sgrùdaidhean
- Rhode Island3 sgrùdaidhean
- Sgìre Cholumbia4 sgrùdaidhean
- South Carolina3 sgrùdaidhean
- South Dakota3 sgrùdaidhean
- Tennessee10 sgrùdaidhean
- Texas13 sgrùdaidhean
- Utah3 sgrùdaidhean
- Virginia3 sgrùdaidhean
- Washington15 sgrùdaidhean
- West Virginia3 sgrùdaidhean
- Wisconsin5 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
A’ fastadhÌre 1
Aoisean 12 gu 78 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT03802695Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
A’ fastadhÌre 2
365 Days · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06317662CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04375631Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07094750A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
A’ fastadhÌre 1/2
30 Days · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT04065399Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT03683433Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
Suas gu aois 50 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT05322850Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A’ fastadhÌre 3
365 Days – 25 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
A’ fastadhÌre 1/2
Suas gu aois 22 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04726241Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
A’ fastadhÌre 2
Aoisean 1 gu 18 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT06390319Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A’ fastadhÌre 1/2
Aoisean 13 gu 90 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06533579Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
A’ fastadhÌre 1
Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06177067Personalized NK Cell Therapy in CBT
A’ fastadhÌre 2
Aoisean 15 gu 80 · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT02727803Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
A’ fastadhÌre 2
6 Months – 65 Years · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06013423Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT07046078Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
A’ fastadhÌre 4
Aoisean 1 gu 18 · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT06289673Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07216443Allo HSCT Using RIC and PTCy for Hematological Diseases
A’ fastadhÌre 2
Suas gu aois 75 · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT05805605Registry of Older Patients With Cancer
A’ fastadhSgrùdadh amharc
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT01137825Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
A’ fastadhÌre 1
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT06551584211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
A’ fastadhÌre 1/2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT03128034211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
A’ fastadhÌre 1/2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT03670966A Study of Revumenib and Mezigdomide in People With Leukemia
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT07356154Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Ògmh 2026 · NCT04047641Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
6 Months · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT04195633Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.